ClinicalTrials.gg
Not yet recruitingNCT06155058Updated Dec 4, 2023

Robotic Versus Conventional Therapy For Post-Stroke Hand Motoric Recovery

An interventional study of SYREBO and Conventional Mirror Method in Stroke, Physical Disability and Upper Extremity Paresis, sponsored by Hasanuddin University. Not yet recruiting at 3 sites in Indonesia. Open to participants aged 20 Years to 85 Years. Per ClinicalTrials.gov, last updated 2023-12-04.

Sponsored by Hasanuddin University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Feb 2024, 2 years 8 months ago, but the record still lists the study as not yet recruiting.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
20 Years to 85 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 13 studies in Stroke with a site in Indonesia — 7 open to participants now, 8 under way, none of them phase 3. Stroke · Indonesia.

Planned enrollment
6th of 10
40 · median 44
Started
2023
with 2 others
No phase
7 of 13
6 open now
Registered
5th of 13
by date
Lead sponsor
2 of 13
Hasanuddin University

Among the 13 studies in Stroke with a site in Indonesia, this one is the 6th largest by planned enrollment of the 10 interventional ones that give a count, is one of 3 that started in 2023, is one of 7 with no phase, and was the 5th registered.

Stroke

8,283 studies on the registry are indexed under Stroke; 2,065 are open to participants now.

Browse Stroke studies →

Open to participants now

7 of the 13 studies in Stroke with a site in Indonesia are open now. Recruiting first, the newest first:

1 more — sign in →

All 7 open studies →

A study can be open while its sites in Indonesia have not opened yet or have stopped. Only those recruiting at a site in Indonesia →

Who these studies take

Of the 1,418 Stroke studies recruiting now, 698 (49%) set no upper age limit and 281 (20%) stop at 75 or younger; 77 take children under 18; 197 take healthy volunteers.

This study: 20 Years to 85 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 13 studies in Stroke with a site in Indonesia, or all of them as a file.
02

Study summary

This clinical trial aims to compare the effectiveness of Robotic versus conventional mirror therapy among post-stroke patients. The main questions it aims to answer are:

  • Effectiveness of both interventions in hand motoric recovery across time
  • Effectiveness of both interventions in functional outcomes across time
  • Clinical outcome difference between both interventions Participants will be allocated into either a robotic group as the main intervention or a mirror therapy group as the active comparator. A serial follow-up will be conducted to assess the selected clinical outcome and differences in outcome
Read the detailed description
  1. Research design This research is an experimental study with a randomized controlled trial research design.
  2. Study Setting The research will be carried out among post-stroke patients at two teaching hospitals and one physical rehabilitation centre in Makassar
  3. Procedure

    1. Robotic Procedure an exoskeletal robot (Syrebo) will help and stimulate the movement of the paralyzed extremity. One set of training covering Activity Daily Living (ADL) set will be conducted. A mirror will reflect the movement of the healthy extremities
    2. Conventional Method the difference from the robotic procedure was, the movement and stimulation will be provided by the physical therapist.
  4. Time frame the procedure will be conducted in parallel three times per week for a total of six weeks
  5. Outcomes

    1. motoric ability of upper extremity using Fugl-Meyer Assessment for Upper Extremities (FMA-UE)
    2. Dexterity, coordination and response of finger using the Nine Hole Peg Test (NHPT)
  6. Covariates and potential confounders

    1. type of stroke determined by radiology imaging
    2. phase of stroke (acute, sub-acute or chronic)
    3. cognitive ability measured using mini-mental state examination (MMSE)
    4. Spasticity measured by the Modified Ashworth Scale (MAS)
  7. Procedure The data collected is primary data obtained in accordance with the inclusion criteria.

    Samples who are willing to become research subjects will undergo interviews, physical examinations, FMA-UE-Hand Motor Domain and NHPT examinations. The interview questionnaire in this study will contain a list of patient identities including name, age, marital status, address, educational history, employment history, history of stroke, cognitive examination (MMSE), and self-reported visual ability.

    The FMA-UE-Hand Motor Domain scoring system is used to evaluate upper extremity motor function in patients with neurological disorders, such as stroke. The scoring system ranges from 0-14, with higher scores indicating better motor function. The FMA-UE-Hand Motor domain assessment system is broken down into several subscales, namely Mass Flexion and Extension movements, followed by functional movements of grasping (Grasp), including Hook Grasp, Thumb Adduction, Pincer Grasp, Cylinder Grasp, and Spherical Grasp. The assessment will get a score of 0 = None or no movement, 1 = Partial or limited movement, and 2 = Full or perfect movement.

    The NHPT assessment consists of a square board with 9 pegs. At one end of the board, there is a hole for the peg, and at the other end, there is a shallow round plate for holding the peg. NHPT is performed by having the patient take pegs from a container, one at a time, and place them into the holes in a board, as quickly as possible. The patient must then remove the pegs from the holes, one at a time, and reinsert them into the housing. To practice and register initial scores, the test must be started with the unaffected upper limb. The board should be placed in the centre of the patient's body with the housing holding the pegs oriented toward the hand being tested. Only the hand being evaluated should perform the test. The non-evaluated hand is allowed to grip the edge of the board to provide stability. Patients are scored based on the time required to complete the test activity, recorded in seconds. The stopwatch must start from the moment the participant touches the first peg until the last peg touches the container. This assessment requires a board, of wood or plastic, with 9 holes (10 mm diameter, 15 mm depth), spaced 32 mm or 50 mm apart and a stopwatch.

  8. Sample Size Based on previous research, the value of the standard deviation of the selected outcome = 11.5 and the value of x1-x2 = 9.1 (Lin, 2020). The Zα value = 1.96 with a confidence interval of 95% and the Zβ value = 0.84 with a power of 80%, two arms and a dropout rate of 30% at least 40 participants should be recruited. A consecutive sampling will be applied and allocated randomly using the simple randomization technique.
  9. Proposed Statistical Analysis Data on the effect of robotic mirror therapy compared to conventional mirror therapy will be assessed using the independent t-test. Data from the FMA-UE and NHPT assessments before and after the intervention will be analyzed using the paired t-test. Next, the relationship between the FMA-UE and NHPT values will be assessed using the Pearson correlation test (normally distributed data) or the Spearman test (data not normally distributed) to determine how big the correlation is between these variables.
03

Conditions studied

  • Stroke
  • Physical Disability
  • Upper Extremity Paresis

Browse trials for

Keywords

  • Robotic Therapy
  • Mirror Therapy
  • Post-Stroke
  • Upper Extremities
  • Motoric Function
  • Functional Outcome
04

Who can participate

Ages eligible
20 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Patients aged 20 - 85 years.
  2. Non-haemorrhagic stroke/infarction with onset more than 3 months from the onset of the attack.
  3. Patients with unilateral upper limb hemiparesis.
  4. Modified Ashworth Scale (MAS) on fingers and hands \<3
  5. The patient has not undergone mirror therapy treatment before.
  6. Patients who are able to understand to participate in research.
  7. The patient had a Radiology imaging of the head at the time of stroke onset.

Exclusion criteria

Exclusion criteria:

  1. Patients with severe spasticity or contractures of the upper extremities.
  2. Patients with infarction/bleeding with extensive lesions covering 2 hemispheres.
  3. The patient has severe cognitive impairment that will interfere with the research objectives ( score >24).
  4. Patients post Digital Subtraction Angiography (DSA) procedures in the last 2 months.
  5. Patients with a history of seizures or epilepsy.
  6. Patients with visual field deficits or severe visual impairment.
  7. Patients who are unable to sit upright without assistance.
  8. Other uncontrolled medical conditions (musculoskeletal, neuromuscular, cardiorespiratory) that may interfere with the ability to exercise.

Dropout criteria:

Patients were excluded from the study if:

  1. Participant dies.
  2. Participants take part in the exercise \<3 times for 2 consecutive weeks.
  3. The participant refuses to continue the training session.
  4. Participants experience hemodynamic disorders during the training program phase.
  5. Participants experience neurological disorders during the training program phase.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    Robotic Mirror Therapy

    Serial training with the help of exoskeletal robot therapy

    Procedure: SYREBO

  • Active comparator
    Conventional Mirror Therapy

    Serial training with the help of physical therapist

    Procedure: Conventional Mirror Method

Interventions

  • ProcedureSYREBO

    Serial ADL training of upper extremities with robotic aid

  • ProcedureConventional Mirror Method

    Serial ADL training of upper extremities assisted by physical therapist

06

What researchers measure

Primary outcomes

  1. FMA-UE Score

    a motoric assessment with each score range from 0-2 with a total score range from 0-66. Higher score indicates better and free movement

    Time frame: changes of FMA-UE score from pre-intervention to six weeks after intervention

  2. NHPT value

    an assessment for finger dexterity and coordination where the time of the subject to accomplish task will be recorded. Average healthy adult male completed the NHPT in 19.0 seconds (SD 3.2) with the right hand, and in 20.6 seconds (SD 3.9) with the left hand. For healthy adult women, the NHPT was completed in 17.9 seconds (SD 2.8) and 19.6 seconds (SD 3.4) with the right and left hands, respectively.

    Time frame: changes of NHPT values from pre-intervention to six weeks after intervention

07

Study locations

3 sites
  • Cerebellum Clinic
    Makassar, South Sulawesi 90231, Indonesia
  • Hasanuddin University, Faculty of Medicine
    Makassar, South Sulawesi 90245, Indonesia
    • Bumi Herman, MD · Contactbumiherman@med.unhas.ac.id · +62411591331
    • Steven Kurniawan, MD · Principal investigator
    • Yose Waluyo, MD, PhD · Principal investigator
    • Husnul Mubarak, MD, PhD · Principal investigator
    • Nuralam Sam, MD, PhD · Principal investigator
  • Wahidin Sudirohusodo General Hospital
    Makassar, South Sulawesi 90245, Indonesia
    • Bumi Herman, Ph.D. · Contactbumiherman@med.unhas.ac.id · +62 411 583333
    • Steven Kurniawan, MD · Principal investigator
    • Nuralam Sam, MD. PhD · Principal investigator
    • Husnul Mubarak, MD · Principal investigator
    • Yose Waluyo, MD, PhD · Principal investigator
    • Andi A Zainuddin, MD, PhD · Sub investigator
    • Andi A Mochtar, Dr, Eng · Sub investigator
08

References and documents

Publications

  • Beom J, Koh S, Nam HS, Kim W, Kim Y, Seo HG, Oh BM, Chung SG, Kim S. Robotic Mirror Therapy System for Functional Recovery of Hemiplegic Arms. J Vis Exp. 2016 Aug 15;(114):54521. doi: 10.3791/54521. PubMed 27583794 ↗
  • Bohannon RW, Smith MB. Interrater reliability of a modified Ashworth scale of muscle spasticity. Phys Ther. 1987 Feb;67(2):206-7. doi: 10.1093/ptj/67.2.206. PubMed 3809245 ↗
  • Chowdhury, Z., 2018. Effectiveness of Mirror Therapy on hand function improvement among patients with chronic stroke. IOSR Journal of Nursing and Health Science (IOSR-JNHS) e-ISSN: 2320-1959.p- ISSN: 2320-1940 Volume 4, Issue 6 Ver. V (Nov. - Dec. 2015), PP 01-04
  • Hijikata N, Kawakami M, Ishii R, Tsuzuki K, Nakamura T, Okuyama K, Liu M. Item Difficulty of Fugl-Meyer Assessment for Upper Extremity in Persons With Chronic Stroke With Moderate-to-Severe Upper Limb Impairment. Front Neurol. 2020 Nov 16;11:577855. doi: 10.3389/fneur.2020.577855. eCollection 2020. PubMed 33304304 ↗
  • Lee MM, Cho HY, Song CH. The mirror therapy program enhances upper-limb motor recovery and motor function in acute stroke patients. Am J Phys Med Rehabil. 2012 Aug;91(8):689-96, quiz 697-700. doi: 10.1097/PHM.0b013e31824fa86d. PubMed 22469877 ↗
  • Nogueira NGHM, Parma JO, Leao SESA, Sales IS, Macedo LC, Galvao ACDR, de Oliveira DC, Murca TM, Fernandes LA, Junqueira C, Lage GM, Ferreira BP. Mirror therapy in upper limb motor recovery and activities of daily living, and its neural correlates in stroke individuals: A systematic review and meta-analysis. Brain Res Bull. 2021 Dec;177:217-238. doi: 10.1016/j.brainresbull.2021.10.003. Epub 2021 Oct 7. PubMed 34626693 ↗
  • Rothgangel AS, Braun SM, Beurskens AJ, Seitz RJ, Wade DT. The clinical aspects of mirror therapy in rehabilitation: a systematic review of the literature. Int J Rehabil Res. 2011 Mar;34(1):1-13. doi: 10.1097/MRR.0b013e3283441e98. PubMed 21326041 ↗
  • Schrader M, Sterr A, Kettlitz R, Wohlmeiner A, Buschfort R, Dohle C, Bamborschke S. The effect of mirror therapy can be improved by simultaneous robotic assistance. Restor Neurol Neurosci. 2022;40(3):185-194. doi: 10.3233/RNN-221263. PubMed 35848045 ↗

Individual participant data

Plan to share: No — To protect the confidentiality, should the data need to share, any de-identified data will be shared for peer-review

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Dec 2023; primary completion for Feb 2024, 2 months later.

Of 3,121 non-industry interventional studies with no phase under Stroke, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 46. This study's planned 2 months is below that.

Counting every sponsor, half of 3,265 studies reached it within 23 months; a quarter within 10 and three quarters within 46.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 24, 2023
First posted
Dec 4, 2023
StartEst.
Dec 1, 2023
Primary completionEst.
Feb 28, 2024
CompletionEst.
Mar 30, 2024
Last update
Dec 4, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 4, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06155058
Lead sponsor
Hasanuddin University
Responsible party
Bumi Herman (Assistant Lecturer, Hasanuddin University) — Principal investigator
First posted
Dec 4, 2023
Start date
Dec 1, 2023 (estimated)
Primary completion
Feb 28, 2024 (estimated)
Completion
Mar 30, 2024 (estimated)
Last update
Dec 4, 2023

Study contacts

Steven Kurniawan, MD
Contact
stvn.aupp@gmail.com
+6281319912162
Steven Kurniawan, MD
principal investigator · Hasanuddin University
Nuralam Sam, MD. Ph.D
principal investigator · Hasanuddin University
Husnul Mubarak, MD
principal investigator · Hasanuddin University
Yose Waluyo, MD. PhD
principal investigator · Hasanuddin University
Andi A Zainuddin, MD.Phd
principal investigator · Hasanuddin University
Andi A Mochtar, Dr. Eng
principal investigator · Hasanuddin University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion